Last reviewed · How we verify
NH004 tropicamide
At a glance
| Generic name | NH004 tropicamide |
|---|---|
| Sponsor | NeuroHealing Pharmaceuticals Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients (PHASE2)
- Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- NH004 tropicamide CI brief — competitive landscape report
- NH004 tropicamide updates RSS · CI watch RSS
- NeuroHealing Pharmaceuticals Inc. portfolio CI